Utility of the BRAFT1799Amutation in papillary thyroid cancer
10.3760/cma.j.issn.1000-6699.2011.06.021
- VernacularTitle:BRAFT1799A基因突变在甲状腺乳头状癌临床诊治中的意义
- Author:
Haixia GUAN
;
Mingzhao XING
- Publication Type:Journal Article
- Keywords:
Papillary thyroid cancer;
BRAF mutation;
Clinical significance
- From:
Chinese Journal of Endocrinology and Metabolism
2011;27(6):525-528
- CountryChina
- Language:Chinese
-
Abstract:
Significant progress has been made toward understanding the tumorigenic role and clinical significance of the T1799A B-type Raf kinase(BRAF)mutation in papillary thyroid cancer(PTC). With these advances, it has become clearer that BRAF mutation will likely have significant impact on the clinical management.
